Daratumumab in lupus đŚ â results of our single-arm trial:
10 patients 8x daratumumab (1/week) at week 12:
âď¸ reduced dsDNA antibodies
âď¸ Median SLEDAI 12 > 4
âď¸ SRI-4 at 12 weeks 100%
âď¸ immunology improved*
out now at @nature.com Communications: www.nature.com/articles/s41...
#medsky #nephsky 𧪠1/
Lennard Ostendorf
